Search research articles
Contact Us
Filters
Showing results (181-190 of 245) with videos related to
Page
of 25
Sort By:
The New England Journal of Medicine
|
April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infection
Bruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.
Journal of Clinical Gastroenterology
|
November 2, 2013
Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response
Stuart C Gordon, K Rajender Reddy, Ira M Jacobson, et al.
Chemistry & Biology
|
November 5, 2013
Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth
Shivani Garapaty-Rao, Christopher Nasveschuk, Alexandre Gagnon, et al.
Hepatology (Baltimore, Md.)
|
June 23, 2010
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
Stephen A Harrison, Lorenzo Rossaro, Ke-Qin Hu, et al.
Journal of Hepatology
|
December 3, 2013
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)
Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
Molecular Psychiatry
|
June 22, 2011
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
A K Smith, J S Simon, E L Gustafson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 19, 2012
Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors
Christiane M Bode, Alessandro A Boezio, Brian K Albrecht, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptor
Stephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
The New England Journal of Medicine
|
April 1, 2011
Boceprevir for untreated chronic HCV genotype 1 infection
Fred Poordad, Jonathan McCone, Bruce R Bacon, et al.
Hepatology (Baltimore, Md.)
|
May 24, 2012
Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin
Ira M Jacobson, Patrick Marcellin, Stefan Zeuzem, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 245) with videos related to
Sort By:
Page
of 25
The New England Journal of Medicine
|
April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infection
Bruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.
Journal of Clinical Gastroenterology
|
November 2, 2013
Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response
Stuart C Gordon, K Rajender Reddy, Ira M Jacobson, et al.
Chemistry & Biology
|
November 5, 2013
Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth
Shivani Garapaty-Rao, Christopher Nasveschuk, Alexandre Gagnon, et al.
Hepatology (Baltimore, Md.)
|
June 23, 2010
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
Stephen A Harrison, Lorenzo Rossaro, Ke-Qin Hu, et al.
Journal of Hepatology
|
December 3, 2013
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)
Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
Molecular Psychiatry
|
June 22, 2011
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
A K Smith, J S Simon, E L Gustafson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 19, 2012
Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors
Christiane M Bode, Alessandro A Boezio, Brian K Albrecht, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptor
Stephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
The New England Journal of Medicine
|
April 1, 2011
Boceprevir for untreated chronic HCV genotype 1 infection
Fred Poordad, Jonathan McCone, Bruce R Bacon, et al.
Hepatology (Baltimore, Md.)
|
May 24, 2012
Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin
Ira M Jacobson, Patrick Marcellin, Stefan Zeuzem, et al.
Page
of 25